HSOA Stock Overview Provides post-acute healthcare services in the United States and Puerto Rico. More details
Rewards Risk Analysis See All Risk Checks Capture your thoughts, links and company narrative
Encompass Health Corporation Competitors Price History & Performance
Summary of share price highs, lows and changes for Encompass Health Historical stock prices Current Share Price US$95.00 52 Week High US$99.00 52 Week Low US$67.50 Beta 0.80 1 Month Change 4.97% 3 Month Change 4.40% 1 Year Change 39.71% 3 Year Change 61.02% 5 Year Change 27.52% Change since IPO 303.72%
Recent News & Updates
Encompass Health Corporation Provides Earnings Guidance for 2025 Feb 07
Encompass Health Corporation to Report Q4, 2024 Results on Feb 06, 2025 Jan 09
Third quarter dividend of US$0.17 announced Dec 30
Third quarter 2024 earnings released: EPS: US$1.09 (vs US$0.86 in 3Q 2023) Oct 29
Encompass Health Corporation Raises Earnings Guidance for Full Year 2024 Oct 29
Dividend of US$0.17 announced Oct 21 See more updates
Encompass Health Corporation Provides Earnings Guidance for 2025 Feb 07
Encompass Health Corporation to Report Q4, 2024 Results on Feb 06, 2025 Jan 09
Third quarter dividend of US$0.17 announced Dec 30
Third quarter 2024 earnings released: EPS: US$1.09 (vs US$0.86 in 3Q 2023) Oct 29
Encompass Health Corporation Raises Earnings Guidance for Full Year 2024 Oct 29
Dividend of US$0.17 announced Oct 21
Encompass Health Corporation Declares Quarterly Cash Dividend on Common Stock, Payable on January 15, 2025 Oct 17
Encompass Health Corporation to Report Q3, 2024 Results on Oct 28, 2024 Oct 11
Upcoming dividend of US$0.17 per share Sep 24
Second quarter 2024 earnings released: EPS: US$1.15 (vs US$0.93 in 2Q 2023) Aug 06
Encompass Health Corporation Raises Earnings Guidance for Full Year 2024 Aug 06
Dividend of US$0.17 announced Jul 29 Encompass Health Declares Dividend on Common Stock, Payable on October 15, 2024 Jul 24
Encompass Health Corporation to Report Q2, 2024 Results on Aug 05, 2024 Jul 12 Encompass Health Corporation(NYSE:EHC) dropped from Russell Small Cap Comp Growth Index
Chief Medical Officer recently sold €783k worth of stock May 26
First quarter dividend of US$0.15 announced May 06
Encompass Health Declares Dividend on Common Stock, Payable on July 15, 2024 May 03
Encompass Health Corporation Provides Earnings Guidance for 2024 Apr 26
First quarter 2024 earnings released: EPS: US$1.14 (vs US$0.89 in 1Q 2023) Apr 25
Encompass Health Corporation to Report Q1, 2024 Results on Apr 24, 2024 Apr 11
Encompass Health Corporation, Annual General Meeting, May 02, 2024 Apr 03
Encompass Health Corporation Appoints Andrew Baird as Senior Vice President of Public Policy, Legislation and Regulations Mar 28
Upcoming dividend of US$0.15 per share Mar 21
Fourth quarter dividend of US$0.15 announced Mar 01
Full year 2023 earnings released: EPS: US$3.66 (vs US$2.57 in FY 2022) Feb 08
Encompass Health Corporation Provides Earnings Guidance for the Year 2024 Feb 08
Encompass Health Corporation to Report Q4, 2023 Results on Feb 07, 2024 Jan 11
Upcoming dividend of US$0.15 per share at 0.9% yield Dec 22
Encompass Health Corporation Appoints Edward M. Christie III to Its Board of Directors Nov 29
Encompass Health Corporation Appoints Edward M. Christie III to Its Board of Directors Nov 28
Encompass Health Corporation Revises Earnings Guidance for the Year 2023 Oct 28
Third quarter 2023 earnings released: EPS: US$0.87 (vs US$0.64 in 3Q 2022) Oct 27
Encompass Health Corporation to Report Q3, 2023 Results on Oct 26, 2023 Oct 07
Upcoming dividend of US$0.15 per share at 0.9% yield Sep 22
Chief Medical Officer recently sold €531k worth of stock Aug 20
Encompass Health Corporation Updates Earnings Guidance for the Full-Year 2023 Aug 03
Encompass Health Corporation Declares Quarterly Cash Dividend, Payable on October 16, 2023 Jul 22
Encompass Health Corporation to Report Q2, 2023 Results on Aug 01, 2023 Jul 14
Upcoming dividend of US$0.15 per share at 0.9% yield Jun 23
First quarter 2023 earnings released: EPS: US$0.89 (vs US$0.88 in 1Q 2022) Apr 30
Investor sentiment improves as stock rises 16% Apr 06
Upcoming dividend of US$0.15 per share at 1.2% yield Mar 24
Full year 2022 earnings released: EPS: US$2.59 (vs US$4.15 in FY 2021) Feb 09
Encompass Health Corporation Provides Earnings Guidance for the Full Year 2023 Feb 08
Encompass Health Corporation to Report Q4, 2022 Results on Feb 07, 2023 Jan 12
Upcoming dividend of US$0.15 per share Dec 23
High number of new directors Nov 16
Independent Director recently bought €101k worth of stock Nov 02
Encompass Health Corporation Revises Earnings Guidance for the Year 2022 Oct 29
Third quarter 2022 earnings released: EPS: US$0.64 (vs US$1.01 in 3Q 2021) Oct 27
Encompass Health Corporation Declares Quarterly Cash Dividend, Payable on January 17, 2023 Oct 20
Encompass Health Corporation to Report Q3, 2022 Results on Oct 26, 2022 Sep 30
Upcoming dividend of US$0.15 per share Sep 23
Second quarter 2022 earnings released: EPS: US$0.49 (vs US$1.14 in 2Q 2021) Aug 02
Encompass Health Corporation Affirms Earnings Guidance for the Year 2022 Aug 02
Encompass Health Corporation Declares Dividend on Common Stock, Payable on October 17, 2022 Jul 21
Encompass Health Corporation to Report Q2, 2022 Results on Aug 01, 2022 Jul 08
Upcoming dividend of US$0.28 per share Jul 05
Investor sentiment deteriorated over the past week Jul 02
Encompass Health Corporation completed the Spin-Off of Enhabit, Inc. (NYSE:EHAB). Jul 02
Encompass Health Corporation Revises Earnings Guidance for the Full Year 2022 Jun 08
Insider recently bought €63k worth of stock May 11
Encompass Health Corporation Declares Quarterly Cash Dividend on Common Stock, Payable on July 20, 2022 May 06
First quarter 2022 earnings released: EPS: US$0.88 (vs US$1.08 in 1Q 2021) Apr 28
Encompass Health Corporation Reaffirms Its Revenue Guidance for the Full Year 2022 Apr 28
Encompass Health Corporation, Annual General Meeting, May 05, 2022 Apr 05
Encompass Health Corporation Announces Board Changes Apr 01
Upcoming dividend of US$0.28 per share Mar 24
Encompass Health's Home Health Unit Reportedly Attracts Acquisition interest Mar 07
Encompass Health Corporation Declares Dividend on Common Stock, Payable on April 18, 2022 Feb 26
Full year 2021 earnings: Revenues and EPS in line with analyst expectations Feb 02
Encompass Health Corporation Provides Earnings Guidance for the Year 2022 Feb 02
Jana Partners Pushes Encompass Health to Pursue a Possible Merger Dec 30
Upcoming dividend of US$0.28 per share Dec 25
Third quarter 2021 earnings released: EPS US$1.01 (vs US$0.78 in 3Q 2020) Oct 28
Upcoming dividend of US$0.28 per share Sep 23
Second quarter 2021 earnings released: EPS US$1.15 (vs US$0.34 in 2Q 2020) Jul 28
Upcoming dividend of US$0.28 per share Jun 23
Chief Executive Officer of Home Health & Hospice April Anthony has left the company Jun 21
Encompass Health Corporation (NYSE:EHC) completed the acquisition of Home Health and Hospice Assets of Frontier Home Health and Hospice from Frontier Home Health and Hospice. Jun 02
Encompass Health Corporation Declares Quarterly Cash Dividend on Common Stock, Payable on July 15, 2021 May 07
First quarter 2021 earnings released: EPS US$1.08 (vs US$0.88 in 1Q 2020) May 01
Encompass Health Corporation Revises Earnings Guidance for the Year 2021 Apr 29
Encompass Health Corporation (NYSE:EHC) entered into a definitive agreement to acquire Home Health and Hospice Assets of Frontier Home Health and Hospice from Frontier Home Health and Hospice. Apr 27
Upcoming dividend of US$0.28 per share Mar 25
Senior VP & Chief Accounting Officer recently sold €589k worth of stock Mar 10
Full year 2020 earnings released: EPS US$2.87 (vs US$3.65 in FY 2019) Mar 01
Revenue beats expectations Mar 01
Revenue beats expectations Jan 28
Full year 2020 earnings released: EPS US$2.88 (vs US$3.65 in FY 2019) Jan 28
New 90-day high: €71.00 Jan 22
Encompass Health Corporation to Report Q4, 2020 Results on Jan 26, 2021 Jan 06
Upcoming Dividend of US$0.28 Per Share Dec 24
Encompass Health Corporation (NYSE:EHC) and Premier Health Partners, Inc. acquired 51% interest in 45-Bed Inpatient Rehabilitation Unit in Dayton, OH. Dec 13
New 90-day high: €69.50 Dec 10
Insider recently sold €422k worth of stock Nov 21 Shareholder Returns HSOA DE Healthcare DE Market 7D 1.1% -1.6% 2.7% 1Y 39.7% 28.6% 17.0%
See full shareholder returns
Return vs Market: HSOA exceeded the German Market which returned 17% over the past year.
Price Volatility Is HSOA's price volatile compared to industry and market? HSOA volatility HSOA Average Weekly Movement 3.3% Healthcare Industry Average Movement 4.5% Market Average Movement 4.8% 10% most volatile stocks in DE Market 11.1% 10% least volatile stocks in DE Market 2.5%
Stable Share Price: HSOA has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: HSOA's weekly volatility (3%) has been stable over the past year.
About the Company Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.
Show more Encompass Health Corporation Fundamentals Summary How do Encompass Health's earnings and revenue compare to its market cap? HSOA fundamental statistics Market cap €9.68b Earnings (TTM ) €436.95m Revenue (TTM ) €5.12b
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) HSOA income statement (TTM ) Revenue US$5.37b Cost of Revenue US$3.14b Gross Profit US$2.23b Other Expenses US$1.77b Earnings US$458.50m
Last Reported Earnings
Dec 31, 2024
Earnings per share (EPS) 4.55 Gross Margin 41.56% Net Profit Margin 8.53% Debt/Equity Ratio 76.5%
How did HSOA perform over the long term?
See historical performance and comparison Dividends
0.7% Current Dividend Yield
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2025/02/16 12:04 End of Day Share Price 2025/02/14 00:00 Earnings 2024/12/31 Annual Earnings 2024/12/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github .
Analyst Sources Encompass Health Corporation is covered by 34 analysts. 12 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution null RESEARCH DEPARTMENT Avondale Partners Matthew Gillmor Baird Ishan Majumdar Baptista Research
Show 31 more analysts 
